{{Rsnum
|rsid=8082134
|Gene=MPO
|Chromosome=17
|position=58275265
|Orientation=plus
|GMAF=0.01837
|Gene_s=MPO
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 98.5 | 1.5 | 0.0
| HCB | 94.9 | 5.1 | 0.0
| JPT | 97.6 | 2.4 | 0.0
| YRI | 84.4 | 12.2 | 3.4
| ASW | 89.5 | 10.5 | 0.0
| CHB | 94.9 | 5.1 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 78.2 | 21.8 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 87.8 | 9.6 | 2.6
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22959522
|Title=The Association Between Polymorphisms in Prooxidant or Antioxidant Enzymes (Myeloperoxidase, SOD2, and CAT) and Genes and Prostate Cancer Risk in the Chinese Population of Han Nationality
}}

{{PMID Auto
|PMID=23260186
|Title=Association Between the Myeloperoxidase Gene Polymorphisms and the Susceptibility to Prostate Cancer: A Case-Control Study in a Chinese Population
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}